Bone Growth Stimulator Market, By Product (Protein Rich Plasma, Bone Growth Stimulation Device and Bone Morphogenetic protein), By Application (Delay Union & Non-Union bone fracture, Spinal fusion and Oral-Maxillofacial), By End-user (Hospital, Academic, Homecare and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

The Global Bone Growth Stimulator Market accounted for US$ 1.34 Billion 2020 and is estimated to be US$ 2.14 Billion by 2030 and is anticipated to register a CAGR of 5.3%.

A Bone Growth Stimulator is a type of supplemental therapy that works by enhancing the body's natural healing process by utilizing the potential provided by bones. This can be utilised as an alternative to bone surgery to allow for easier access and minimum difficulties during procedures, as well as a reduction in patient non-compliance. They are also known as osteogenesis stimulators, and they emit ultrasound without causing discomfort. They are particularly use during cervical and lumbar spine surgery. Pulsed electromagnetic field devices, capacitive coupling devices, and combined magnetic field devices are the three types of bone growth stimulation devices available. Bone growth stimulators use electrical current or ultrasonic waves to encourage bone healing during treatments for union and non-union fractures, new fractures, and unsuccessful spinal fusions. Demand for bone growth stimulators is predicted to rise as the number of vertebral fractures and associated consequences rises. These devices are expected to be widely employed to treat delayed union and non-union bone fractures, which make up a sizable portion of the market.

Restraining factors

High treatment costs associated with BMP and PRP products, as well as limited medical reimbursement for bone stimulation products, are limiting considerations. The market overall expansion has also been hampered by frequent product recalls. Product recalls have a negative impact on a company’s business and reputation. Customers loyalty to a company’s other products may be affected as a result of this. Furthermore, recalls cast doubt on the efficacy of new products, delaying their acceptance by surgeons. For example, the FDA categorized Zimmer Biomet's SpF XL IIb and SpF PLUS-Mini implantable spinal stimulators as a Class I recall in May 2017. This recall was issued due to the presence of potentially dangerous compounds that could cause serious side effects such as paralysis, persistent infections, and death.

Prevalence of trauma and accident cases

One of the primary variables anticipated to enhance demand for the studied market is an increase in the prevalence of trauma and accident cases around the world. Factors including the ageing population, rising incidence of orthopaedic problems like osteoporosis and degenerative joint disorders, and a preference for minimally or non-invasive surgeries are all helping to drive the industry forward. During the treatment of various fractures and spinal procedures, bone morphogenetic proteins (BMP) and platelet-rich plasma (PRP) products aid in bone development. As a result of the speedier healing and recovery, it is expected that the use of these items would grow during these surgeries. Furthermore, an increase in patient awareness of bone growth stimulators, procedural benefits provided by bone growth stimulation devices in the treatment of bone fractures and orthopaedic diseases, technological advancements in bone growth stimulators, and an increase in the adoption rate of bone growth stimulators by both patients and prescribers are all factors that contribute to the growth of the industry.

The global Bone growth stimulator market is segmented based on product, application, end-user and region.

On the basis of product, the global Bone growth stimulator market is segmented into Protein rich plasma, Bone growth stimulation device and Bone morphogenetic protein. Based on application, the target market is segmented into Delay Union & Non-union bone fracture, Spinal fusion and Oral maxillofacial. On the basis of end-user, the target market is segmented into Hospital, Academics, Homecare and Others.

Regional Insights:

On region the global Bone growth simulator market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominating the bone growth stimulator market. This is mainly attributed due to high prevalence of osteoporosis or vertebral fractures in this region. Due to the high need for novel therapies for chronic conditions and the local presence of significant medical device manufacturers like as Medtronic, Orthofix Holdings, Inc., Zimmer Biomet, Bioventus, Stryker, and Terumo BCT, Inc., Europe was the second-largest market for bone growth stimulators. Furthermore, the regional market is likely to be driven by highly developed healthcare infrastructure, particularly in Germany, Switzerland, the United Kingdom, and France. Due to the rising number of traffic accidents and trauma cases in this region, Asia-Pacific is predicted to be the fastest-growing region in terms of bone growth stimulator market growth.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global Bone growth stimulator market report based on product, application, end-user and region.

Global Bone Growth Stimulator Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the global Bone growth stimulator market includes Zimmer Biomet, Bioventus, Synergy Orthopedics, Ito Co., Ltd., DePuy Synthes, DJO Global, Ossatec Benelux BV, Orchid Medical Centre, TERUMO BCT, INC., Isto Biologics,, Arthrex, Inc., Smith & Nephew,  Stryker, Medtronic, Orthofix Holdings, Inc., Ember Therapeutics., Regen Lab SA and elizur Corporation and Others. To maintain dominance in this market, key companies have used product releases and advancements, strategic acquisitions, and market expansions as their main business strategies.

• Zimmer Biomet*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Bioventus
• Synergy Orthopedics
• Ito Co., Ltd.
• DePuy Synthes
• DJO Global
• Ossatec Benelux BV
• Orchid Medical Centre
• TERUMO BCT INC.
• Isto Biologics
• Arthrex Inc.
• Smith & Nephew
• Stryker
• Medtronic
• Orthofix Holdings Inc.
• Ember Therapeutics.
• Regen Lab SA
• Elizur Corporation and Others.

 “*” marked represents similar segmentation in other categories in the respective section